Anybody can explain, why yesterday price 0.24 and today 0.10 ?

Throwback News....
https://www.thestar.com.my/business/business-news/2020/01/20/borneo-oil-the-main-supplier-to-lahad-datu-limestone-plant

This news not related with Bornoil. But more to explanation of heavy Share buy back by company.
https://www.theedgemarkets.com/article/frankly-speaking-sale-treasury-shares-timely

Who still have bullet and believe under value, just buy.... It's normal, people like kejar harga tinggi compare masa harga rendah. It's normal.

Buy before fly high

[New post] Malaysia SafeTravelPass for all China students and travelers payment facilitation of Covid-19 Screening Test, Vaccine Check, Quarantine, Accommodation, MyTravelPass and E-Visa verification, effectively 1st January 2021. [5 Jan 2021]

MATERIAL PRESS RELEASE

Kuala Lumpur, Malaysia (December 31 2020):  Nexgram Holdings Berhad (“the Company” or “Nexgram”) subsidiary Tri-G Technologies Sdn Bhd (“Tri-G”) today signed China Panel Government System Integrator Contract (“CHINA-PGSIC”) with Wan Sheng Ke Advisory Service Shenzhen Limited (“Wan  Sheng Ke”), dedicated to facilitate all China foreign students and travelers from China the one stop payment portal for the application of SafeTravelPass (STP) which facilitates the Covid-19 Screening Test, Vaccine Check, Quarantine, Accommodation, immigration department’s MyTravelPass and E-Visa verification, trial run effective 1st January 2021, in conjunction to government announcement on accepting foreign students on the same date.

The portal is ready for International travelers online payment especially foreign students studying in Malaysia prior to entering Malaysia. The portal is facilitating payment from 8 countries and territories namely China, Taiwan, Singapore, Brunei, Japan, South Korea, New Zealand, and Australia, all with local language and domestic electronic currency payment acceptance. China is the first foreign country got awarded the PGSIC contract by the company.

According to the contract, “Wan Sheng Ke” shall integrate, customize, and scale the charging system to fit with China stakeholders’ requirements, to host decentralized local regulated data within local cloud data service providers, to handle minimum 2,000,000 travelers from China a year for period of two (2) years to Malaysia, starting 1st January 2021. 

Upon “Wan Sheng Ke” secured other International registration and connectivity of SafeTravelPass in China, SafeTravelPass shall also cater for other outbound travelers from China to the world. 

In year 2019, international arrivals into China amounted to approximately 145.31 million; international arrivals in Malaysia amounted to approximately 26.1 million; whereas China arrivals in Malaysia amounted to approximately 2.9 million according to Statistic report. 

There were approximately 13,450 international students from China studying in Malaysia. 

According to New Straits Times, the Senior Minister (Security Cluster) Datuk Seri Ismail Sabri Yaakob quoted starting Jan 1, foreign students at private education institutes, except those arriving from the United Kingdom, will be allowed to enter Malaysia. Students would have to adhere to the guidelines and procedures set by the Immigration Department, National Security Council and National Disaster Management Agency from time to time. Only existing students who had already obtained approval and visa from Immigration Department would be allowed to enter.

"The students have to take the Covid-19 test three days prior to their departure and another test upon arrival at our international arrival points”, commented Senior Minister.

To recall, Nexgram awarded the Panel Government System Integrator Contract (“PGSIC”) to OTTIGO Sdn Bhd which is developed to collect payment on behalf of agencies and stakeholders including Agensi Pengurusan Bencana Negara (“NADMA”), Immigration Department, airport, Covid-19 swabbers & laboratories, hotels and travel agencies etc, for inbound travellers facilitation in Covid-19 screening tests, quarantine, accommodation, and coming vaccine tracing on all airports, and borders in Malaysia. The application came with ready vaccine tracing system, trackable and accessible worldwide. 

To date, the system is ready with multi-language portal including English, Bahasa Malaysia, Chinese Simplified, Chinese Traditional, Indonesian, Korean, Japanese, and Thai, with localized payment and digital health pass ready worldwide.

The Tracvirus Open Platform is similar to International e-commerce platform, open to all qualified vendors and stakeholders to register, and there is no cost to the government utilization. The platform is designed in compliance to Bank Negara FATF, AMLA and ISO 20022 standards for user privacy and data security protection, as well as implementation of highest standard of anti-unauthorised medical data prevention system. The platform came with artificial intelligence (“AI”) module to divert travelers and tests traffic to under-served capacities during airport or border rush hours, intended to solve single vendor risk and bottleneck when comes to Covid-19 pandemic capacity limitation. Authorities and airports uses Tracvirus to monitor and prevent single vendor site service break down and contamination risk, either in terms of payment vendors, swabbers, laboratories, or transportation logistics, and other value added services.

https://www.klsescreener.com/v2/news/view/771417

https://www.theedgemarkets.com/article/tech-and-healthcare-stocks-lead-equities-2021-recovery-says-principal-asset

https://www.hmetro.com.my/mutakhir/2020/12/657511/kerajaan-pertimbang-buka-sempadan-untuk-tingkatkan-pelancongan?fbclid=IwAR3QkT2u6TN721wk3mbRTSwAtVKsHMbo3qIqrzm9F7Fhn2v26HgqXTtKlJo

Base on current development and deal secured by Nexgram, Most big project from government. Possible Nexgram is government proxy to deal with vaccine. Furthermore, they have connection, capability to do that. Covid is really real deal to Nexgram.

Vaccine news 25/11, I think tak ramai orang tahu. Or jerung takde orang dalam, kalau tak hari ni dah lompat. Nexgram ni biasanya dah 2, 3 hari deal baru announce. Positifnya, Nexgram ni memang betul2 buat kerja. Bukan nak dapat duit dari share trading. Anyway, soon sure lompat punya. Grab la berapa banyak yg boleh selagi harga murah ni.

https://www.klsescreener.com/v2/news/view/758165

Chart will forming handle now, close over 7, will rocket up to sky. Base on chart, need 2 or 3 days, but anything is possible.

Today will rise, if can close at 5.5 / 6, is good for chart... Higher is bonus, chart show everything..

Just realised, everybody rushing for vaccine but nobody care the vial bottle.... Expected vial bottle shortage worldwide, Very huge opportunity to Nexgram when time come.

https://www.washingtonpost.com/business/2020/07/13/coronavirus-vaccine-corning-glass/

Nexgram target to secure capacity glove order 4.8 billion in 4th qtr this year.. Means this mth they should able to. Below contract + Covid tester + Tracvirus, should realise in next Qtr report.

Currently the company is authorised to supply 12 million boxes (or 1.2 billion pieces) of nitrile gloves a year capacity, and had recently secured conditional contract of 500,000 boxes a month, for a period of 3 years, to supply Indonesia tender bidding through local wholesale distributor. The company through several strategic alliances is targeted to secure capacity of 48 million boxes (or 4.8 billion pieces) of gloves a year by 4th quarter 2020.

Glove Alliance carries OEM brands such as K-Gloves Nitrile Examination Gloves Powder-Free, which is non-sterile, coral blue, nitrile butadiene rubber, beaded cuff, ambidextrous superior quality gloves, which came with S, M and L sizes. Besides nitrile gloves, the company has secured supplies of 500,000 pieces of medical Isolation Gown up to 2 million pieces capacity per month

1. The source of the supply of the PPE i.e. the gown and medical gloves to NBSB for NBSB’s onward distribution to MAPU. NBSB get the supply from Crecom Burj Gloves Sdn Bhd which NBSB is the appointed representative for AAMI Isolation Gown and K-Gloves Nitrile Examination.
2. Total capital and/or investment outlay required of NEXGRAM and/or NBSB in respect of the venture into the distribution of PPE to MAPU.
No capital or investment outlay is required by NBSB as the customer is required to pay the deposit of their order.
3. Clarification on whether the sale of PPE to MAPU requires any government approvals in Malaysia and/or Indonesia. If yes, please state the government approvals NBSB needs to obtain and the status of such approvals.
PPE is not required approval from Medical Device Authority. However, MAPU will apply the special access approval from Kementerian Kesehatan Republik Indonesia upon each delivery.
4. The commencement and expiry dates of the sale of the Products to MAPU as stipulated in the Agreement.
The first delivery of the order for AAMI Isolation Gown and K-Gloves Nitrile Examination Gloves-Powder Free will be on November 2020.

Next Qtr result should show some prove base on their project achievements. The result should be good. Grab before too late

Just grab Nexg. as much as you can before fly. Eventually the price will move, just matter of time

https://klse.i3investor.com/m/blog/rubberglove_y2023/2020-11-22-story-h1536553150-AT_0072_Prediction_value_by_June_2021.jsp

Nexgram target to secure capacity glove order 4.8 billion in 4th qtr this year.. Means this mth they should able to.

Currently the company is authorised to supply 12 million boxes (or 1.2 billion pieces) of nitrile gloves a year capacity, and had recently secured conditional contract of 500,000 boxes a month, for a period of 3 years, to supply Indonesia tender bidding through local wholesale distributor. The company through several strategic alliances is targeted to secure capacity of 48 million boxes (or 4.8 billion pieces) of gloves a year by 4th quarter 2020.

Glove Alliance carries OEM brands such as K-Gloves Nitrile Examination Gloves Powder-Free, which is non-sterile, coral blue, nitrile butadiene rubber, beaded cuff, ambidextrous superior quality gloves, which came with S, M and L sizes. Besides nitrile gloves, the company has secured supplies of 500,000 pieces of medical Isolation Gown up to 2 million pieces capacity per month

Tak faham, boleh google what mean cup

Nexgram now will form cup and handle pattern. Once lepas resistance, will shoot up to the sky.

Use worldwide bro....
https://nexgram.co/2020/11/18/digital-health-passport-safetravelpass-begins-international-testing-to-help-travel-and-trade-resume-18-nov-2020-press-release/

Both owned by Nexgram. But nobody see the potential

Glove vs Vaccine
https://www.theedgemarkets.com/article/covid19-rhb-says-vaccine-deployment-could-generate-demand-18-billion-pieces-gloves-year

Go and study Careplus chart, same thing happen to AT now. just believe base on fact. See Careplus price now. Same thing happen to careplus before, hater come when price down and quiet when up. They as well not believe careplus can go more than 1 ringgit. Who said AT down until 9 sen, I think you know nothing about technical. in fact, current chart still support uptrend. This is normal price up and down.

Don't worry, base on chart showing start beginning uptrend. Ochimoku cloud start green. Estimate within this few days, start up again. This is normal correction unless broke downtrend. To newbie, I'm advice study technical instead of follow blindly what peopke say. Especially hater... If know technical, it will guide you to do what you need to do.

Hope this project relate to Nxg since their strong connection with government now. they have own division for vaccine

https://www.klsescreener.com/v2/news/view/754921

Base on chart, end of today or tomorrow, should rise.

This is old news, but enough to explain AT plan. 13 line at Chemor and 7 line at new plant. Mean their attention to setup others plan, not at PG. Before announcement, already make the plan to setup at new plant.

https://www.thesundaily.my/business/at-systematization-s-line-1-glove-production-nears-completion-AI4846057

AT Systematization Bhd’s Line 1 glove dipping facility is 80% completed and the first batch of medical-grade nitrile gloves set to be produced in less than two months.

Its “plant within a plant” approach has accelerated the setting up process in the facility in Chemor, Perak which started five months ago in mid-July this year, compared to the usual one year taken by new entrants to glove business to complete their manufacturing facility.

The group said the facility will be made compatible with Industrial 4.0 (IR4.0) ecosystem, equipped with Manufacturing Executive System (MES) to provide real-time production monitoring and control, output control and monitoring, record retention to comply with standard regulations.

Its managing director Choong Lee Aun said it aims to have a “smart and high-tech” glove production business, to which there are plans to build an additional three-storey office building with IT room, production control room and office workplace for its team.

Production of Line 1 will commence in early December 2020, which would enable revenue contribution for the new glove business to begin in FY2021 and for every subsequent two months it will install two new glove dipping lines.

AT estimated that its glove production capacity to reach 2.6 billion glove pieces per annum by June 2021, based on round-the-clock production.

It revealed that each of its single former production line can run at a speed of 15,000 pieces of gloves per hour whereas each double former production line can run at a speed of 24,000 pieces of gloves per hour, effectively making it a strong proxy to the robust global glove demand.

The group estimated an annual turnover of RM860 million for the venture based on its maximum capacity and an average selling price assumption of US$80 (RM333) per 1,000 nitrile gloves.

This represents more than 40 fold increase over its annual turnover of roughly RM20 million for the financial year ended March 31, 2020.

By mid 2021, AT is expected to have one single former and 12 double former glove dipping line, and it is currently working on the 13th line due to a stronger-than-expected demand ahead of production.

It will invest a total RM120 million for the 13 dipping lines, along with the related facilities and new building.

Ultimately, the group aims to have a total of 20 lines, which will be installed in a new line in a new plant.

Choong stated that it is confident that the new glove manufacturing business will break even in less than a year.

“We have already received overwhelming response and queries on orders from foreign and local buyers, even before we start production. The tremendous demand is well beyond our expectations, and we are working fast to meet this huge demand.”

The managing director acknowledged that the rising glove price momentum might not be sustainable once a Covid-19 vaccine is developed, he believes that the long-term growth prospects remain intact, given the increased awareness of the importance of gloves following the pandemic.

Nevertheless, AT’s strategy following the pandemic is to implement digital manufacturing technologies such as plant equipment automation, advanced robotics and additive manufacturing.

“This initiative is in line with our core business of designing and manufacturing industrial automation systems and precision engineering solutions.”

Choong stated that the group aims to venture into the provision of design, engineering and technology works, fabrication as well as installation of machines for the manufacturing of gloves and other rubber related products in two to three years.

No need to argue can buy or not. Target TP 0.70. Even others company just plan or intend to buy, not yet start anything can shoot up to unreasonable price. No need talk about PE, future earning, cash or debt, related with glove price can shoot up until over our imagination. Just see GETS, Mahsing,not start anything, but price already rocket up. Even AT, had proof factory, line setup, target production, earning forecast, some people still argue to buy? Market, if you're really afraid to loss money, better do not trade. I dare to say, even expert, they loss sometime. Most important, you know what you buy, having technical knowledge, do not blindly follow others.

Real deal business is Tracvirus and Vaccine bottle. Tracvirus is first in the world maybe. Can imagine if this system really use by all country? Since Nexgram already setup the base system, others just can direct use it.

Nexgram real deal is Tracvirus

Tracvirus, use for others countries as well. Mainly Indon. The company had secured connectivity in foreign countries and shall be used in Indonesia, Hong Kong, Taiwan, Arab Saudi and most of European countries

Chart showing start uptrend. No more turning back.

At last, volume coming

Really Started..... Such a dream, tuju langit

https://www.wionews.com/world/volunteers-face-severe-hangover-headache-and-pain-after-getting-pfizer-vaccine-shot-342518

After Pfizer's claim that the COVID-19 vaccine is more than 90% effective based on initial trial results, a few volunteers said that they suffered side effects comparable to a flu jab, with one comparing them to "a severe hangover".

Around 43,500 people in six countries have taken part in the phase three trial run by the pharmaceutical giant and its partner BioNTech.

One of the volunteers of the trial, Texas lobbyist Glenn Deshields compared side effects of the shot as being similar to "a severe hangover" whereas another one, 45-year old Carrie said that she went through fever, body aches and headache after the second shot. 

Carrie also said that signing up for the trial was a “civic duty” and said Monday’s positive news left her feeling “very proud”.She said that 'There are so many people who have had it and suffered.'She had received her first shot back in September and her second last month.

This is good thing anyway, flush contra

Really crazy, contra player, I think all flush out already

Already Share the logic and fact, but not believe? . Who sold will regret. Believe hater no bring you any good thing. Know what you buy,
Not blindly buy without knowing anything.

Please read and digest the reason abort the acquisition.
Super good news will release soon as well related to acquisition which solve about license and others related approval issue.

AT Systematization Shifts Focus To Its Own Gloves Production
- Focus on its own gloves plant would lead to production of its first batch by Dec 2020
- Capacity expansion of its own plant is faster than proposed acquisition of Pearl Glove

This news insider already since Oct. Just officially announce yesterday.
In fact, price still rocket up..
AT Systematization Berhad (“ATS” or “Group”) has decided to abort its proposed acquisition of Pearl Glove (Malaysia) Sdn Bhd (PGSB), in order to focus and expedite the setup of its glove manufacturing plant in Perak and aimed to deliver its first batch of medical-grade nitrile gloves by the end of this year. During the course of due diligence, it was revealed that certain matters discovered were not in line with the representation made by the Vendors of PGSB. As these are not in line with the Group’s expectation, it was decided to terminate the proposed acquisition and move forward to focus on its own gloves production. Instead of adopting multiple growth strategies such as the proposed acquisition of PGSB, ATS would be laser-focus on completing its glove manufacturing factory. The focus is expected to enable its glove plants to be setup in just five months as compared to the average of one-year taken for glove manufacturing facility to be completed via proposed acquisition of PGSB.

Hour chart, Last call before shoot up

Hourly chart showing price will up, maybe before afternoon we can see the movement

Today if no price up also ok. Chart showing very high buying momentum.

Already Share the logic and fact, but not believe? . Who sold will regret. Believe hater no bring you any good thing.

Please read and digest the reason abort the acquisition.
Super good news will release soon as well related to acquisition which solve about license and others related approval issue.

AT Systematization Shifts Focus To Its Own Gloves Production
- Focus on its own gloves plant would lead to production of its first batch by Dec 2020
- Capacity expansion of its own plant is faster than proposed acquisition of Pearl Glove

AT Systematization Berhad (“ATS” or “Group”) has decided to abort its proposed acquisition of Pearl Glove (Malaysia) Sdn Bhd (PGSB), in order to focus and expedite the setup of its glove manufacturing plant in Perak and aimed to deliver its first batch of medical-grade nitrile gloves by the end of this year. During the course of due diligence, it was revealed that certain matters discovered were not in line with the representation made by the Vendors of PGSB. As these are not in line with the Group’s expectation, it was decided to terminate the proposed acquisition and move forward to focus on its own gloves production. Instead of adopting multiple growth strategies such as the proposed acquisition of PGSB, ATS would be laser-focus on completing its glove manufacturing factory. The focus is expected to enable its glove plants to be setup in just five months as compared to the average of one-year taken for glove manufacturing facility to be completed via proposed acquisition of PGSB.

Who sold, regret...

Ants materialise or not for IPO is no issue. Business still running.

Please read and digest the reason abort the acquisition.
Super good news will release soon as well related to acquisition which solve about license and others related approval issue.

AT Systematization Shifts Focus To Its Own Gloves Production
- Focus on its own gloves plant would lead to production of its first batch by Dec 2020
- Capacity expansion of its own plant is faster than proposed acquisition of Pearl Glove

AT Systematization Berhad (“ATS” or “Group”) has decided to abort its proposed acquisition of Pearl Glove (Malaysia) Sdn Bhd (PGSB), in order to focus and expedite the setup of its glove manufacturing plant in Perak and aimed to deliver its first batch of medical-grade nitrile gloves by the end of this year. During the course of due diligence, it was revealed that certain matters discovered were not in line with the representation made by the Vendors of PGSB. As these are not in line with the Group’s expectation, it was decided to terminate the proposed acquisition and move forward to focus on its own gloves production. Instead of adopting multiple growth strategies such as the proposed acquisition of PGSB, ATS would be laser-focus on completing its glove manufacturing factory. The focus is expected to enable its glove plants to be setup in just five months as compared to the average of one-year taken for glove manufacturing facility to be completed via proposed acquisition of PGSB.

Soon will be released super good news about acquisition as well.

Please read and digest the reason abort the acquisition.